Biotech firm AVANT Immunotherapeutics of Needham, Mass. has agreed to occupy and build a process development and pilot-manufacturing facility at the UMass Advanced Technology & Manufacturing Center in Fall River.
Over the last several months, the company worked out an agreement with MassDevelopment and the University of Massachusetts Dartmouth.
Beyond Cash Donations: How New Forms of Giving Are Transforming Not-for-Profit Accounting
Evolving Funding Landscape for Not-for-Profits Not-for-profit organizations are being asked to do more with less,…
Learn More
AVANT will establish an 11,000-square-foot process development and pilot manufacturing facility to support the clinical development of its portfolio of bacterial vaccines, including vaccines for biodefense, as well as continue development and product application of its patented thermo-stable preservation technology, VitriLife.
“This is the beginning of what I hope will be an excellent relationship between the city of Fall River and AVANT,” said Fall River Mayor Edward M. Lambert Jr. “We would love to within a few short years, watch AVANT expand and perhaps build an even larger facility, providing even more jobs.”
